Canadian Theatre Review is the major magazine of record for Canadian theatre. It is committed to excellence in the critical analysis and innovative coverage of current developments in Canadian theatre, to advocating new issues and artists, and to publishing at least one significant new playscript per issue. The editorial board is committed to CTR's practice of theme issues that present multi-faceted and in-depth examinations of the emerging issues of the day and to expanding the practice of criticism in Canadian theatre and to the development of new voices.
NRC Research Press, the publishing arm of the National Research Council of Canada (NRC) since 1929, transitioned in September 2010 from NRC and the Federal Government of Canada into an independent not-for-profit organization operating under the new name Canadian Science Publishing.
The peer-reviewed quarterly journal Canadian-American Slavic Studies is edited and published to provide information about Slavic and East European (including Albania, Hungary and Romania) culture, past and present, in a scholarly context. The journal began publication in Montreal, Québec, Canada in 1967 and then continued publication in the USA in 1971. It publishes articles, documents, translations and book reviews in the English, French, German, Russian and Ukrainian languages. It also features special issues about specific topics prepared by guest editors. Most of the material has featured contributions about history and literature, but the journal welcomes contributions in all areas of the humanities and social sciences.
The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. The print and online versions of the journal are published by John Wiley & Sons, Inc.
Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.
Cancer Causes & Control is an international refereed journal that both reports and stimulates new avenues of investigation into the causes, control, and subsequent prevention of cancer. Its multidisciplinary and multinational approach draws together information published in a diverse range of journals. Coverage extends to variation in cancer distribution within and between populations; factors associated with cancer risk; preventive and therapeutic interventions on a population scale; economic, demographic, and health-policy implications of cancer; and related methodological issues.Cancer Causes & Control publishes original and review articles, hypotheses, comments, opinions, and letters which have direct relevance to researchers and practitioners working in epidemiology, medical statistics, cancer biology, health education, medical economics and related fields. The journal also provides significant information for government agencies concerned with cancer research, control and policy.